Basis and principles of radiopharmaceuticals for PET/CT. Wadsak W, Mitterhauser M. Eur J Radiol. 2010;73(3):461-469
Stability of 11C-labeled PET radiopharmaceuticals.
Fukumura T, Nakao R, Yamaguchi M, Suzuki K. Appl Radiat Isot. 2004 Dec;61(6):1279-87.
Radiofármacos PET. Peñuelas I. Rev Esp Med Nucl. 2001;20(3):477-98
Radioembolization with 90Y-microspheres for liver tumors
Radioembolization in liver tumours
18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis.
García Vicente AM, Delgado-Bolton R, Amo-Salas M, López-Fidalgo J, Caresia Aróztegui AP, García Garzón JR, Orcajo Rincón J, García Velloso MJ, de Arcocha Torres M, Álvarez Ruíz S. Eur J Nucl Med Mol Imaging. 2017; 44(9):1575-1587.
PET/TC con 68Ga-PSMA en el cáncer de próstata. Rev Esp Med Nucl Imagen Mol. 2018 Mar – Apr;37(2):130-138. DOI: 10.1016/j.remn.2017.07.004
José Ramón García, María de arcocha torres, Roberto Delgado-Bolton, Francesco Ceci, Soledad Álvarez, Javier Orcajo Rincón, Ana Paula Caresia, María José Garcia-Velloso, Ana María García Vicente.
SEOM-SERAM-SEMNIM Guideline on the Use of Functional and Molecular Imaging Techniques in Advanced Non-small-cell lung Cancer. Clin Transl Oncol. 2018 Jul;20(7):837-852.
Gabriel Fernández Pérez, Ricardo Sánchez-Escribano Morcuende, Ana María García Vicente, Antonio Luna Alcalá, Jaime Ceballos Viro, Roberto C. Delgado-Bolton, Joan Carles Vilanova Busquets, Pedro Sánchez Rovira, María Patricia Fierro Alanis, Roberto García Figueiras, José Enrique Alés Martínez.
PET/CT in breast cancer: Evidence based recommendations in initial staging. Tumour Biol. 2017 Oct;39(10):1010428317728285. DOI:10.1177/1010428317728285.
Caresia Aróztegui AP, García Vicente AM, Álvarez Ruiz S, Delgado Bolton RC, Orcajo Rincón J, García Garzón JR, Arcocha Torres M, García Velloso MJ. 18F-FDG PET/CT in breast cancer: Evidence based recommendations in initial staging. Tumour Biol. 2017 Oct;39(10):1010428317728285. DOI:10.1177/1010428317728285.
Radium-223 in the treatment of bone metastasis in patients with castration-resistant prostate cancer. Review and procedure.Rev Esp Med Nucl Imagen Mol 37 (5), 330-337 Sep-Oct 2018. DOI: 10.1016/j.remn.2018.02.007
Orcajo-Rincon, A.P. Caresia-Aróztegui,∗, M. del Puig Cózar-Santiago, J.R. García-Garzón, M. de Arcocha-Torres, R.C. Delgado-Bolton, M.J. García-Velloso, S. Alvarez-Ruiz y A.M. García-Vicente.